• Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice. Kneepkens EL, Plasencia C, Krieckaert CL, Pascual-Salcedo D, van der Kleij D, Nurmohamed MT, L√≥pez-Casla MT, Wieringa R, Rispens T, Wolbink G. Ann Rheum Dis 2014; 73(12):2217-9.

 

  • Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. van Schouwenburg PA, Rispens T, Wolbink GJ. Nat Rev Rheumatol 2013; 9(3):164-72. Epub 2013 Feb 12. Review.